SCHEMBL2725664

SCHEMBL2725664

Fc1cc(F)c(F)c(-c2c3ccccc3c(-c3ccccc3)c3c(F)ccc(F)c23)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.42
CYP3A4 P08684 5/20 0.42
CYP2C19 P33261 5/20 0.42
CYP2C9 P11712 4/20 0.42
KDM4E B2RXH2 3/20 0.35
MAPT P10636 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP2D6 P10635 1/20 0.33
POLB P06746 2/20 0.33
MAP2 P11137 1/20 0.33
ACHE P22303 2/20 0.33
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
HTT P42858 2/20 0.32
LMNA P02545 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
AR P10275 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2727461 0.91 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL2726679 0.89 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C19CYP2C9KDM4E
SCHEMBL2941870 0.89 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL2726578 0.89 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19CYP2C9KDM4E
SCHEMBL2728102 0.89 MAOB (0.36) CYP1A2CYP3A4CYP2C19CYP2C9KDM4E
SCHEMBL2937924 0.88 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL2724904 0.87 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C19CYP2C9KDM4E
SCHEMBL2942023 0.87 NPC1 (0.35) CYP1A2CYP3A4CYP2C19CYP2C9ALDH1A1
SCHEMBL2711448 0.86 CYP1A2 (0.50) CYP1A2CYP3A4CYP2C19CYP2C9KDM4E
SCHEMBL2725978 0.86 CYP1A2 (0.34) CYP1A2CYP3A4CYP2C19CYP2C9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 CYP1A2 22/4885CYP3A4 18/4885CYP2C19 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.